Cargando…

Biosensor-guided improvements in salicylate production by recombinant Escherichia coli

BACKGROUND: Salicylate can be biosynthesized from the common metabolic intermediate shikimate and has found applications in pharmaceuticals and in the bioplastics industry. While much metabolic engineering work focused on the shikimate pathway has led to the biosynthesis of a variety of aromatic com...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Shuai, Li, Ye, Cirino, Patrick C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350385/
https://www.ncbi.nlm.nih.gov/pubmed/30696431
http://dx.doi.org/10.1186/s12934-019-1069-1
_version_ 1783390444463325184
author Qian, Shuai
Li, Ye
Cirino, Patrick C.
author_facet Qian, Shuai
Li, Ye
Cirino, Patrick C.
author_sort Qian, Shuai
collection PubMed
description BACKGROUND: Salicylate can be biosynthesized from the common metabolic intermediate shikimate and has found applications in pharmaceuticals and in the bioplastics industry. While much metabolic engineering work focused on the shikimate pathway has led to the biosynthesis of a variety of aromatic compounds, little is known about how the relative expression levels of pathway components influence salicylate biosynthesis. Furthermore, some host strain gene deletions that improve salicylate production may be impossible to predict. Here, a salicylate-responsive transcription factor was used to optimize the expression levels of shikimate/salicylate pathway genes in recombinant E. coli, and to screen a chromosomal transposon insertion library for improved salicylate production. RESULTS: A high-throughput colony screen was first developed based on a previously designed salicylate-responsive variant of the E. coli AraC regulatory protein (“AraC-SA”). Next, a combinatorial library was constructed comprising a series of ribosome binding site sequences corresponding to a range of predicted protein translation initiation rates, for each of six pathway genes (> 38,000 strain candidates). Screening for improved salicylate production allowed for the rapid identification of optimal gene expression patterns, conferring up to 123% improved production of salicylate in shake-flask culture. Finally, transposon mutagenesis and screening revealed that deletion of rnd (encoding RNase D) from the host chromosome further improved salicylate production by 27%. CONCLUSIONS: These results demonstrate the effectiveness of the salicylate sensor-based screening platform to rapidly identify beneficial gene expression patterns and gene knockout targets for improving production. Such customized high-throughput tools complement other cell factory engineering strategies. This approach can be generalized for the production of other shikimate-derived compounds. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-019-1069-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6350385
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63503852019-02-04 Biosensor-guided improvements in salicylate production by recombinant Escherichia coli Qian, Shuai Li, Ye Cirino, Patrick C. Microb Cell Fact Research BACKGROUND: Salicylate can be biosynthesized from the common metabolic intermediate shikimate and has found applications in pharmaceuticals and in the bioplastics industry. While much metabolic engineering work focused on the shikimate pathway has led to the biosynthesis of a variety of aromatic compounds, little is known about how the relative expression levels of pathway components influence salicylate biosynthesis. Furthermore, some host strain gene deletions that improve salicylate production may be impossible to predict. Here, a salicylate-responsive transcription factor was used to optimize the expression levels of shikimate/salicylate pathway genes in recombinant E. coli, and to screen a chromosomal transposon insertion library for improved salicylate production. RESULTS: A high-throughput colony screen was first developed based on a previously designed salicylate-responsive variant of the E. coli AraC regulatory protein (“AraC-SA”). Next, a combinatorial library was constructed comprising a series of ribosome binding site sequences corresponding to a range of predicted protein translation initiation rates, for each of six pathway genes (> 38,000 strain candidates). Screening for improved salicylate production allowed for the rapid identification of optimal gene expression patterns, conferring up to 123% improved production of salicylate in shake-flask culture. Finally, transposon mutagenesis and screening revealed that deletion of rnd (encoding RNase D) from the host chromosome further improved salicylate production by 27%. CONCLUSIONS: These results demonstrate the effectiveness of the salicylate sensor-based screening platform to rapidly identify beneficial gene expression patterns and gene knockout targets for improving production. Such customized high-throughput tools complement other cell factory engineering strategies. This approach can be generalized for the production of other shikimate-derived compounds. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-019-1069-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-29 /pmc/articles/PMC6350385/ /pubmed/30696431 http://dx.doi.org/10.1186/s12934-019-1069-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Qian, Shuai
Li, Ye
Cirino, Patrick C.
Biosensor-guided improvements in salicylate production by recombinant Escherichia coli
title Biosensor-guided improvements in salicylate production by recombinant Escherichia coli
title_full Biosensor-guided improvements in salicylate production by recombinant Escherichia coli
title_fullStr Biosensor-guided improvements in salicylate production by recombinant Escherichia coli
title_full_unstemmed Biosensor-guided improvements in salicylate production by recombinant Escherichia coli
title_short Biosensor-guided improvements in salicylate production by recombinant Escherichia coli
title_sort biosensor-guided improvements in salicylate production by recombinant escherichia coli
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350385/
https://www.ncbi.nlm.nih.gov/pubmed/30696431
http://dx.doi.org/10.1186/s12934-019-1069-1
work_keys_str_mv AT qianshuai biosensorguidedimprovementsinsalicylateproductionbyrecombinantescherichiacoli
AT liye biosensorguidedimprovementsinsalicylateproductionbyrecombinantescherichiacoli
AT cirinopatrickc biosensorguidedimprovementsinsalicylateproductionbyrecombinantescherichiacoli